Page last updated: 2024-11-02

pirenzepine and Cerebrovascular Disorders

pirenzepine has been researched along with Cerebrovascular Disorders in 1 studies

Pirenzepine: An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mazzarella, B1
Mastronardi, P1
Lettieri, B1
Lo Schiavo, F1
Valentini, P1

Other Studies

1 other study available for pirenzepine and Cerebrovascular Disorders

ArticleYear
[Prevention and treatment of gastro-duodenal hemorrhagic complications in patients with neurologic lesions].
    La Clinica terapeutica, 1983, Sep-15, Volume: 106, Issue:5

    Topics: Adolescent; Adult; Aged; Benzodiazepinones; Brain Injuries; Cerebrovascular Disorders; Female; Gastr

1983